Fan Zhang
University of Vermont(US)Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Shandong University(CN)Shanxi Medical University(CN)Beijing University of Chinese Medicine(CN)Anhui University of Science and Technology(CN)Jilin University(CN)Peking University(CN)Chinese PLA General Hospital(CN)Beijing Jishuitan Hospital(CN)Zhengzhou University(CN)Shaanxi Provincial People's Hospital(CN)Allen Institute for Immunology(US)Shanghai Public Health Clinical Center(CN)Panzhihua University(CN)Anhui Science and Technology University(CN)Henan Provincial People's Hospital(CN)Panzhihua Central Hospital(CN)Zhengzhou People's Hospital(CN)Institute of Crop Sciences(CN)Shenyang The Fourth Hospital of People(CN)Shaanxi Provincial People's Hospital(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Research Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial(2016)937 cited
- → Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming(2021)560 cited
- → Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases(2009)396 cited
- → Coordination of m 6 A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming(2015)289 cited
- → Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade(2018)259 cited
- → A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers